Document is current
Any future updates will be listed below
-
Authors
Vaughan, David P.
Real, Raquel
Jensen, Marte Theilmann
Fumi, Riona G.
Hodgson, Megan
Jabbari, Edwin
Lux, Danielle
Wu, Lesley
,
,
Warner, Thomas T.
Jaunmuktane, Zane
Revesz, Tamas
Rowe, James B.
Rohrer, Jonathan
Morris, Huw R. https://orcid.org/0000-0002-5473-3774
-
Funding
Funding for this research was provided by:
Progressive Supranuclear Palsy Association (PROSPECT2)
Medical Research Council (T033371/1)
Wellcome (220258)
Cambridge Centre for Parkinson-Plus (MC_UU_00030/14)
NIHR Cambridge Biomedical Research Centre (NIHR203312)
- License Information
-
More Information
Article History
Received: 3 November 2024
Revised: 9 February 2025
Accepted: 15 February 2025
First Online: 26 March 2025
Declarations
:
: Dr Morris is employed by UCL. In the last 12 months he reports paid consultancy from Aprinoia and AI Therapeutics; lecture fees/honoraria - Movement Disorders Society. Research Grants from Parkinson’s UK, Cure Parkinson’s Trust, PSP Association, Medical Research Council, Michael J Fox Foundation. Dr Morris is a co-applicant on a patent application related to C9orf72 - Method for diagnosing a neurodegenerative disease (PCT/GB2012/052140).
